STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] NORTHRIM BANCORP INC Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Northrim BanCorp, Inc. entered into Subordinated Note Purchase Agreements with institutional accredited investors and qualified institutional buyers, issuing and selling $60.0 million of its 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035 at 100% of face value in a private placement. The company plans to use the net proceeds for general corporate purposes and to support regulatory capital ratios for growth initiatives.

The Notes bear a fixed interest rate of 6.875% per year from November 26, 2025 to, but excluding, December 1, 2030, then reset quarterly at three-month SOFR plus 348 basis points until maturity on December 1, 2035. They are unsecured, subordinated obligations intended to qualify as Tier 2 capital, are redeemable at the company’s option on or after December 1, 2030 at par plus accrued interest, and are subject to registration rights that provide for an exchange offer into registered notes with substantially the same terms.

Positive

  • None.

Negative

  • None.

Insights

Northrim raises $60M subordinated debt to bolster Tier 2 capital.

Northrim BanCorp has issued $60.0 million of 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035 in a private placement to institutional investors at par. The Notes are unsecured, subordinated obligations and are intended to qualify as Tier 2 capital, which can support balance sheet growth and regulatory capital ratios without immediate equity dilution.

The coupon is fixed at 6.875% until December 1, 2030, after which it converts to a floating rate of three-month SOFR plus 348 basis points, shifting interest cost sensitivity to market rates. The company may, subject to the stated conditions, redeem the Notes at par plus accrued interest on or after December 1, 2030, giving flexibility if funding conditions change.

Registration Rights Agreements commit the company to an exchange offer into registered notes with substantially the same terms, and failure to meet those obligations would trigger additional interest. Overall, this transaction adds long-dated subordinated debt and expands regulatory capital, while increasing interest expense and subordination in the capital stack; the net effect will depend on how the proceeds are deployed in future periods.

0001163370false00011633702025-11-262025-11-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,  D.C. 20549 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 26, 2025(November 26, 2025)
Northrim BanCorp, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Alaska0-3350192-0175752
________________________
(State or other jurisdiction
_____________
(Commission
_________________
(I.R.S. Employer
of incorporation)File Number)Identification No.)
    
3111 C Street,  Anchorage,   Alaska 99503
___________________________________
(Address of principal executive offices)
 ___________
(Zip Code)
Registrant’s telephone number, including area code: 907-562-0062
Not Applicable
___________________________________________________
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None
TITLE OF EACH CLASSTRADING SYMBOLNAME OF EXCHANGE
Common Stock, $0.25 par valueNRIMThe NASDAQ Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.126-2 of this chapter).

                                    Emerging growth company     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨








Item 1.01 Entry into a Material Definitive Agreement.

On November 26, 2025, Northrim BanCorp, Inc. (the “Company”) entered into Subordinated Note Purchase Agreements (the “Purchase Agreements”) with certain institutional “accredited investors,” as such term is defined in Rule 501 of Regulation D promulgated by the U.S. Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”), and “qualified institutional buyers,” as such term is defined in Rule 144A promulgated by the SEC under the Securities Act (collectively, the “Purchasers”). Under the terms of the Purchase Agreements with the Purchasers, the Company issued and sold $60.0 million in aggregate principal amount of its 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035 (the “Notes”). The Notes were issued by the Company to the Purchasers at a price equal to 100% of their face amount.

The Notes were offered and sold by the Company in a private placement transaction in reliance on exemptions from the registration requirements of the Securities Act, pursuant to Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated by the SEC thereunder. The Company intends to use the net proceeds it received from the sale of the Notes for general corporate purposes and to support regulatory capital ratios for growth initiatives. The Purchase Agreements contain certain customary representations, warranties and covenants made by the Company, on the one hand, and the Purchasers, severally and not jointly, on the other hand.

The Notes mature on December 1, 2035 and bear interest at a fixed rate of 6.875% per year, from November 26, 2025 to, but excluding, December 1, 2030 or the date of earlier redemption, payable semi-annually in arrears. From and including December 1, 2030 to, but excluding, the maturity date or earlier redemption date, the interest rate will reset quarterly at a variable rate equal to the then current three-month Secured Overnight Financing Rate (“SOFR”), plus 348 basis points, payable quarterly in arrears. As provided in the Notes, the interest rate on the Notes during the applicable floating rate period may be determined based on a rate other than three-month term SOFR.

Prior to December 1, 2030, the Company may redeem the Notes, in whole but not in part, only under certain limited circumstances set forth in the Indenture (as defined below). On or after December 1, 2030, the Company may redeem the Notes, in whole or in part, at its option, on any interest payment date. Any redemption by the Company would be at a redemption price equal to 100% of the principal amount of the Notes being redeemed, together with any accrued and unpaid interest on the Notes being redeemed to, but excluding, the date of redemption. The Notes are not subject to redemption at the option of the holder.

Principal and interest on the Notes are subject to acceleration only in limited circumstances in the case of certain bankruptcy and insolvency-related events with respect to the Company. The Notes are unsecured, subordinated obligations of the Company, are not obligations of, and are not guaranteed by, any subsidiary of the Company, and rank junior in right of payment to the Company’s current and future senior indebtedness. The Notes are intended to qualify as Tier 2 capital of the Company for regulatory capital purposes.

The Notes were issued under an Indenture, dated November 26, 2025 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). The Notes are not subject to any sinking fund and are not convertible into or exchangeable, other than pursuant to the Exchange Offer (as defined below), for any other securities or assets of the Company or any of its subsidiaries.

On November 26, 2025, in connection with the sale and issuance of the Notes, the Company entered into Registration Rights Agreements (the “Registration Rights Agreements”) with the Purchasers. Under the terms of the Registration Rights Agreements, the Company has agreed to take certain actions to provide for the exchange of the Notes for subordinated notes that are registered under the Securities Act and have substantially the same terms as the Notes (the “Exchange Offer”). Under certain circumstances, if the Company fails to meet its obligations under the Registration Rights Agreements, it would be required to pay additional interest to the holders of the Notes.

The forms of the Purchase Agreements, the Registration Rights Agreements, the Indenture and the Notes are attached as Exhibits 10.1, 10.2, 4.1 and 4.2, respectively, to this Current Report on Form 8-K (this “Form 8-K”) and are incorporated herein by reference. The foregoing descriptions of the Purchase Agreements, the Registration Rights Agreements, the Indenture and the Notes are summaries and are qualified in their entirety by reference to the full text of such documents.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 of this Form 8-K and the full text of the Indenture and form of the Notes, which are attached hereto as Exhibits 4.1 and 4.2, respectively, are incorporated by reference into this Item 2.03.

Item 7.01 Regulation FD Disclosure.

On November 26, 2025, the Company issued a press release announcing the completion of the offering of the Notes, a copy of which is furnished herewith as Exhibit 99.1 to this Form 8-K.




In connection with the offering of the Notes, the Company delivered an investor presentation to potential investors on a confidential basis, a copy of which is furnished herewith as Exhibit 99.2 to this Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Form 8-K, including Exhibits 99.1 and 99.2 furnished herewith, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Form 8-K, including Exhibits 99.1 and 99.2 furnished herewith, shall not be incorporated by reference into any filing or other document pursuant to the Securities Act, except as shall be expressly set forth by specific reference in such filing or document.

Cautionary Note Regarding Forward-Looking Statements

This Form 8-K contains, and future oral and written statements of the Company and its wholly owned banking subsidiary, Northrim Bank (the “Bank”), may contain, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company’s current views with respect to future events and the Company’s financial performance. Any statements about the Company’s expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Forward-looking statements include, but are not limited to: (i) projections and estimates of revenues, expenses, income or loss, earnings or loss per share, and other financial items, (ii) statements of plans, objectives and expectations of the Company or its management, (iii) statements of future economic performance, and (iv) statements of assumptions underlying such statements. Forward-looking statements should not be relied on because they involve known and unknown risks, uncertainties and other factors, some of which are beyond the control of the Company and the Bank. These risks, uncertainties and other factors may cause the actual results, performance, and achievements of the Company and the Bank to be materially different from the anticipated future results, performance or achievements expressed in, or implied by, the forward-looking statements. Due to these and other possible uncertainties and risks, the Company can give no assurance that the results contemplated in the forward-looking statements will be realized and readers are cautioned not to place undue reliance on the forward-looking statements contained in this Form 8-K. Additional information regarding these factors and uncertainties to which the Company’s business and future financial performance are subject is contained in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q on file with the SEC, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of such documents, and other documents the Company files or furnishes with the SEC from time to time. Further, any forward-looking statement speaks only as of the date on which it is made and the Company undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as required by applicable law. All forward-looking statements, express or implied, herein are qualified in their entirety by this cautionary statement.


   
Item 9.01Financial Statements and Exhibits.
 
Exhibit 4.1
Indenture, dated as of November 26, 2025, by and between Northrim BanCorp, Inc. and U.S. Bank Trust Company, National Association, as trustee
Exhibit 4.2
Form of 6.875% Fixed-to-Floating Rate Subordinated Note due December 1, 2035 (included as Exhibit A-1 to the Indenture filed as Exhibit 4.1 hereto)
Exhibit 10.1
Form of Note Purchase Agreement, dated as of November 26, 2025, by and among Northrim BanCorp, Inc. and the Purchasers
Exhibit 10.2
Form of Registration Rights Agreement, dated as of November 26, 2025, by and among Northrim BanCorp, Inc. and the Purchasers
Exhibit 99.1
Press Release issued by Northrim BanCorp, Inc. on November 26, 2025
Exhibit 99.2
Investor Presentation of Northrim BanCorp, Inc.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Northrim BanCorp, Inc.
      
November 26, 2025 By: /s/ Jed W. Ballard
    Name: Jed W. Ballard
    Title: EVP, Chief Financial Officer

FAQ

What did Northrim BanCorp (NRIM) announce in this Form 8-K?

Northrim BanCorp announced it entered into Subordinated Note Purchase Agreements and issued and sold $60.0 million of 6.875% Fixed-to-Floating Rate Subordinated Notes due 2035 in a private placement to institutional investors.

What are the key terms of Northrim BanCorps new subordinated notes?

The Notes mature on December 1, 2035, carry a fixed interest rate of 6.875% per year until, but excluding, December 1, 2030, and thereafter reset quarterly at three-month SOFR plus 348 basis points, with interest payable in arrears.

How does Northrim BanCorp intend to use the $60.0 million in proceeds?

The company intends to use the net proceeds from the sale of the Notes for general corporate purposes and to support regulatory capital ratios for growth initiatives.

Can Northrim BanCorp redeem the 6.875% subordinated notes early?

Prior to December 1, 2030, the company may redeem the Notes in whole, but not in part, only in limited circumstances described in the Indenture. On or after December 1, 2030, it may redeem the Notes, in whole or in part, on any interest payment date at 100% of principal plus accrued and unpaid interest.

How do these subordinated notes rank in Northrim BanCorps capital structure?

The Notes are unsecured, subordinated obligations of Northrim BanCorp, are not obligations of or guaranteed by its subsidiaries, and rank junior in right of payment to the companys current and future senior indebtedness. They are intended to qualify as Tier 2 capital for regulatory purposes.

Did Northrim BanCorp (NRIM) agree to register the new subordinated notes?

Yes. Under Registration Rights Agreements with the purchasers, Northrim BanCorp agreed to take actions to provide for an exchange offer of the Notes for substantially similar subordinated notes registered under the Securities Act, and may owe additional interest if it does not meet those obligations.

How were the Northrim BanCorp subordinated notes offered from a regulatory standpoint?

The Notes were offered and sold in a private placement relying on exemptions from Securities Act registration under Section 4(a)(2) and Rule 506(b) of Regulation D, to institutional accredited investors and qualified institutional buyers.
Northrim Bancorp Inc

NASDAQ:NRIM

NRIM Rankings

NRIM Latest News

NRIM Latest SEC Filings

NRIM Stock Data

560.66M
21.49M
2.78%
74.99%
1.18%
Banks - Regional
Savings Institution, Federally Chartered
Link
United States
ANCHORAGE